Genomic studies to unlock
the truth of active compounds

Genel provides pharmaceutical and cosmetic companies
with new services to enhance personalized care.
Genel proposes innovative approach:

using 3D cellular models and primary cells to highlight active ingredient effects on its gene target
combining bioscreening, new imaging system and bioinformatics to guarantee an effective, fast, reliable and ready-to-use result

Pharma
Cosmetics

GENEL, One of the Key Technologies in France according to the French Ministry of Economy
GENEL, One of the Key Technologies in France according to the French Ministry of Economy
7 November 2016

GENEL was identified as one of the 47 key technologies in France that are considered to have the best strategies in terms of market segment and expertise. In...


So little time so much to do!
So little time so much to do!
Paris | 5 November 2016

A busy but fulfilling month of November coming for GENEL: Founder and CEO Gaelle Saint-Auret will be giving a talk about women in entrepreneuship.


New GenDetox test
New GenDetox test
Grenoble | 12 July 2016

In the countryside, in towns, pollution is in every place. Our skin is damaged every day by organic compounds, fine particles, heavy metals, emission gases,...


L’épigénétique dans la mélanogenèse
L’épigénétique dans la mélanogenèse
Grenoble | 19 January 2016

Une tendance durable : avoir un teint lumineux et lisse. Comment faire pour que notre peau paraisse naturellement éclatante ? La beauté du teint, preuve de...


Genel, lauréate 2015 du Trophée R2B Onco
Genel, lauréate 2015 du Trophée R2B Onco
Lyon | 24 November 2015

Neolys Diagnostics (Lyon) et Genel (Grenoble), deux jeunes sociétés de biotechnologies, ont été récompensées le 24 novembre à Lyon du trophée R2B ONCO...

Genel: Innovation
The key to performance